Log In
person
Novo Nordisk A/S
NONOF
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (DKK) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (DKK) | Percentage |
| Diabetes Care and Obesity |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
156.41B | 88.39% |
| Rare disease |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
20.54B | 11.61% |
| keyboard_arrow_down |
Diabetes Care and Obesity
Branded Pharmaceuticals
|
156.41B | 88.39% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Rare disease
Branded Pharmaceuticals
|
20.54B | 11.61% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||